Boji Pharma Signs RMB 53.57 Million Clinical Trial Service Agreement with Viumbio for VVN001 Ophthalmic Solution

BojiMed announced on January 25 that it has signed a "Clinical Trial Service Agreement" with VIVAVISION. The total contract amount is 53.5713 million yuan (including tax). The contract stipulates that VIVAVISION entrusts BojiMed to provide clinical trial contract research organization services for "VVN001 Eye Drops".